Similar companies
Did Larimar Therapeutics Beat Earnings?
Larimar Therapeutics (LRMR) reported Q2 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Larimar Therapeutics’s job postings, web traffic, and employee business outlook. See the full LRMR stock analysis or the earnings calendar for upcoming reports.
Larimar Therapeutics Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 480,000 | — | — | — | — | — | — |
| Gross margin | — | 50.0% | — | — | — | — | — | — |
| Operating margin | — | -6,492.3% | — | — | — | — | — | — |
| Net income | -15M | -29M | -29M | -26M | -48M | -62M | -30M | -33M |
| Net margin | — | -5,980.1% | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
Larimar Therapeutics Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Larimar Therapeutics’s quarterly revenue moved from $0 to $0.
When Is Larimar Therapeutics’s Next Earnings Date?
Larimar Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the LRMR earnings calendar.
Frequently Asked Questions: Larimar Therapeutics Earnings
Larimar Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Larimar Therapeutics reported Q2 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the LRMR AI Score.
